Kevin is a partner and co-chair of the Intellectual Property practice, a leader of the Patent practice, a member of the Litigation practice, and a co-chair of the Dietary Supplements industry team.
He focuses primarily on litigating intellectual property, unfair competition, and regulatory disputes before federal courts and agencies, the International Trade Commission, and various alternative dispute resolution forums. Kevin has extensive experience in developing and executing strategic counseling to clients regarding the development and enforcement of intellectual property portfolios.
Kevin has developed a substantial practice representing U.S. and international companies across a broad range of technologies that include biotech, pharmaceutical, medical device, dietary supplement, software, semiconductor, and computer science-related matters. He has successfully implemented novel economic theories, which have resulted in substantial monetary damages awards for his clients at trial. He regularly represents clients in investigations and enforcement matters before agencies, such as the FDA, FTC, DOJ, CBP, National Advertising Division (NAD) of the BBB, and state Attorneys’ General. Kevin also assists clients with public policy involving IP and regulatory issues before the agencies and Congress.
Kevin is considered a leading legal advisor in the areas of dietary supplements and natural products. He is highly sought after by companies for his success in providing clients with global strategies to protect and enforce their intellectual property and execute complex, regulatory enforcement efforts in the U.S. and abroad. Kevin has also developed a significant presence in the areas of cannabis and CBDs, as it relates to regulatory, IP, and legislative issues. He leads the firm’s Cannabis/CBD industry team that provides clients with a broad range of legal expertise.